Incluye referencias bibliográficas e índice

Foreword; Preface; Acknowledgements; Contents; Contributors; 1: Introduction of Colorectal Cancer; 1.1 Introduction; 1.2 Epidemiology; 1.3 Causes/Risk Factors; 1.4 Clinical Presentation/Signs and Symptoms; 1.5 Diagnosis; 1.6 Faecal Occult Blood Testing (FOBT); 1.7 X-Ray with Barium Enema; 1.8 Flexible Sigmoidoscopy; 1.9 Colonoscopy; 1.10 CT Colonography; 1.11 Staging Procedures/Investigations; 1.12 Staging of Colon Carcinoma; References; 2: Pathology of Colorectal Cancer; 2.1 Histological Classification of Colorectal Cancers; 2.2 TNM Classification; 2.2.1 Duke Stages.

2.2.2 Prognostic FactorsReferences; 3: Management of Colorectal Cancer; 3.1 Role of the Multidisciplinary Team (MDT); 3.2 Management of Localised Disease; 3.2.1 Surgery for Localised Disease; 3.2.2 Rectal Tumours; 3.3 Adjuvant Treatment in Localised Disease; 3.3.1 Chemotherapy; 3.4 Radiotherapy; 3.4.1 Follow-Up; 3.5 Treatment of Metastatic Colorectal Cancer (mCRC); 3.6 Systemic Therapy; 3.6.1 Cytotoxics; 3.6.1.1 Fluropyrimidine-Based Therapy; 3.6.1.2 Doublet-Chemotherapy Regimens; 3.7 Targeted Agents; 3.7.1 Bevacizumab; 3.8 Cetuximab; 3.9 Aflibercept; 3.10 Regorafenib.

3.11 Role of Surgery in Advanced Colorectal Cancer3.12 Other Modalities of Treatment; References; 4: Radiological Imaging of Colorectal Cancer; 4.1 Staging of Colon Cancers Using CT; 4.2 Assessment of Rectal Cancers; 4.3 Summary of Rectal MRI Assessment Standards for Reporting; 4.3.1 Baseline and Post-treatment Assessment of Rectal Cancer MRI; 4.3.2 Minimum Standards for Reporting:; References; 5: 18F-FDG PET/CT: Normal Variants, Artefacts, and Pitfalls in Colorectal Cancer; 5.1 Introduction; 5.2 Physiological Variants; 5.3 Artefacts and Imaging Pitfalls; 5.4 Technical Artefacts.

5.4.1 Misregistration5.4.2 Partial Volume Effect; 5.4.3 Attenuation Correction Artefacts; 5.4.4 Truncation Artefacts; 5.5 Organ- and Pathology-Specific Pitfalls; 5.5.1 Liver; 5.5.2 Spleen, Pancreas, and Adrenals; 5.5.3 Stomach; 5.5.4 Colon and Small Bowel; 5.5.5 Urinary Tract; 5.5.6 Reproductive System; 5.5.7 Bone; 5.5.8 Muscle; 5.5.9 Lymph Nodes; 5.5.10 Peritoneum; 5.6 Treatment-Related Pitfalls; References; 6: PET/CT in Colorectal Cancer; 6.1 Introduction; 6.2 Primary Diagnosis/Staging; 6.3 Response Assessment; 6.4 Detection of Recurrent Disease.

6.5 Normal Variants and ArtefactsReferences; 7: PET/CT in Colorectal Cancer-Pictorial Atlas; 7.1 Case 1: Typical "Apple-Core" Appearance on CT of a Transverse Colon Primary. CT Staging: T3N2M0; 7.2 Case 2: Sigmoid Colon Primary. CT Staging: T3N2M0; 7.3 Case 3: Adenocarcinoma Within the Splenic Flexure of the Colon. On CT, the Approximately 5 cm Annular Lesion Is in Close Contact with the Anterior Surface and the Upper Pole of the Left Kidney as Illustrated Below. CT Staging: T4N2M0.

This book is a pocket guide to the science and practice of PET/CT imaging of colorectal malignancies. The role of PET/CT in these patients, the characteristic PET/CT findings, and the advantages and limitations of this hybrid modality are all clearly described. In addition, information is provided on clinical presentation, diagnosis, staging, pathology, management, and radiological imaging. The book is published within the Springer series Clinicians' Guides to Radionuclide Hybrid Imaging, which is aimed at nuclear medicine/radiology residents and physicians, referring clinicians, radiographers/technologists, and nurses who routinely work in nuclear medicine and participate in multidisciplinary meetings. Compiled under the auspices of the British Nuclear Medicine Society, the series is the joint work of many colleagues and professionals worldwide who share a common vision and purpose in promoting and supporting nuclear medicine as an important imaging specialty for the diagnosis and management of oncological and non-oncological conditions.